Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$177.8 - $270.58 $15.7 Million - $23.8 Million
-88,046 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$121.0 - $257.67 $8.4 Million - $17.9 Million
-69,441 Reduced 44.09%
88,046 $18.7 Million
Q4 2020

Feb 16, 2021

SELL
$78.74 - $139.5 $528,502 - $936,324
-6,712 Reduced 4.09%
157,487 $17.6 Million
Q3 2020

Nov 13, 2020

BUY
$79.44 - $178.51 $13 Million - $29.3 Million
164,199 New
164,199 $17.8 Million

Others Institutions Holding NVAX

About NOVAVAX INC


  • Ticker NVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 78,215,104
  • Market Cap $704M
  • Description
  • Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...
More about NVAX
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.